2008
DOI: 10.1074/mcp.m700115-mcp200
|View full text |Cite
|
Sign up to set email alerts
|

Protein Expression Profiling of Breast Cancer Cells by Dissociable Antibody Microarray (DAMA) Staining

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
27
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 36 publications
(30 citation statements)
references
References 31 publications
3
27
0
Order By: Relevance
“…Our data are in full agreement with in vitro studies that compared TYK2 levels in different breast cancer cell lines and found them to be higher in ERα(+) cell lines (T47D, MCF7, ZR-75-1) ) when compared to ERα(−) lines (MDA-MB-231, BT549, HS578T, MDA-MB-435S), and immortalized normal lines (MCF10A, MCF12A, and Hs578Bst) [31]. Interestingly, among all breast cancer cell lines analyzed in the latter study, TYK2 levels were the lowest in BT549, a cell line derived from an invasive ductal tumor that had metastasized to 3 of 7 regional lymph nodes [31]. …”
Section: Discussionsupporting
confidence: 90%
“…Our data are in full agreement with in vitro studies that compared TYK2 levels in different breast cancer cell lines and found them to be higher in ERα(+) cell lines (T47D, MCF7, ZR-75-1) ) when compared to ERα(−) lines (MDA-MB-231, BT549, HS578T, MDA-MB-435S), and immortalized normal lines (MCF10A, MCF12A, and Hs578Bst) [31]. Interestingly, among all breast cancer cell lines analyzed in the latter study, TYK2 levels were the lowest in BT549, a cell line derived from an invasive ductal tumor that had metastasized to 3 of 7 regional lymph nodes [31]. …”
Section: Discussionsupporting
confidence: 90%
“…Contrasting data were recently found by a dissociable antibody microarray (DAMA), a technique that combines protein microarrays with traditional immunostaining, on normal and cancer breast cell lines showing that p107 is one of the upregulated proteins in cancer compared to normal cells (119). Data were confirmed by Western blot analysis and statistical analysis leading the authors to consider p107 a candidate biomarker for breast cancer diagnosis.…”
Section: P107supporting
confidence: 50%
“…Tomasson and colleagues describe a potential association of Tyk2 germ-line sequence changes to acute myelogenous leukemia pathogenesis. Elevated Tyk2 expression levels detected in breast cancer cell lines prompted the authors to propose Tyk2 as a potential biomarker for breast cancer diagnosis (22). Moreover, loss of Tyk2 expression and signaling has been shown to inhibit the invasiveness of human prostate cancer cells (23) and of leukemic B cells in a murine model system of human Burkitt's lymphoma (24).…”
Section: Introductionmentioning
confidence: 99%